The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
SAMe, Choline, and Valproic Acid as Possible Epigenetic Drugs: Their Effects in Pregnancy with a Special Emphasis on Animal Studies
Abstract
In this review, we discuss the functions and main effects on pregnancy outcomes of three agents that have the ability to induce epigenetic modifications: valproic acid (VPA), a well-known teratogen that is a histone deacetylase inhibitor; S-adenosylmethionine (SAMe), the most effective methyl donor; and choline, an important micronutrient involved in the one methyl group cycle and in the synthesis of SAMe. Our aim was to describe the possible effects of these compounds when administered during pregnancy on the developing embryo and fetus or, if administered postnatally, their effects on the developing child. These substances are able to modify gene expression and possibly alleviate neurobehavioral changes in disturbances that have epigenetic origins, such as autism spectrum disorder (ASD), depression, Rett syndrome, and fetal alcohol spectrum disorder (FASD). Valproic acid and SAMe are antagonistic epigenetic modulators whether administered in utero or postnatally. However, VPA is a major human teratogen and, whenever possible, should not be used by pregnant women. Most currently relevant data come from experimental animal studies that aimed to explore the possibility of using these substances as epigenetic modifiers and possible therapeutic agents. In experimental animals, each of these substances was able to alleviate the severity of several well-known diseases by inducing changes in the expression of affected genes or by other yet unknown mechanisms. We believe that additional studies are needed to further explore the possibility of using these substances, and similar compounds, for the treatment of ”epigenetic human diseases”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiologic studies have shown that there is 3–5% increase rate of ASD among offspring of epileptic mothers, who at the time of pregnancy undertake valproic acid (VPA) treatment, compared to the general population [66].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [66]
In the citing paper
“Exposing pregnant rodents to VPA has been established as a modeling tool for studying ASD-like behavior [49,66,67].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advances in epigenetics link genetics to the environment and disease
Cavalli, G., & Heard, E. (2019) · Nature · doi:10.1038/s41586-019-1411-0 · Cited by 1,509 · cited 1×
“Epigenetic changes are related to a variety of congenital malformations and diseases [1,72,73].”
BackgroundPrenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013) · JAMA · doi:10.1001/jama.2013.2270 · Cited by 1,357
Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526
Self-citationCharacteristics of fetal anticonvulsant syndrome associated autistic disorder
Rasalam, A., Hailey, H., Williams, J., Moore, S., Turnpenny, P., Lloyd, D., & Dean, J. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205001076 · Cited by 456
Ingram, J. L., Peckham, S. M., Tisdale, B., & Rodier, P. M. (2000) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(99)00083-5 · Cited by 381
Valproate Induces Replication-independent Active DNA Demethylation
Detich, N., Bovenzi, V., & Szyf, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303740200 · Cited by 345
Loss of Tet Enzymes Compromises Proper Differentiation of Embryonic Stem Cells
Dawlaty, M. M., Breiling, A., Le, T., Barrasa, M. I., Raddatz, G., Gao, Q., Powell, B. E., Cheng, A. W., Faull, K. F., Lyko, F., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.03.003 · Cited by 338
Niculescu, M. D., Craciunescu, C. N., & Zeisel, S. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-4707com · Cited by 330
Mechanisms involved in the developmental programming of adulthood disease
Warner, M. J., & Ozanne, S. E. (2010) · Biochemical Journal · doi:10.1042/bj20091861 · Cited by 316 · cited 1×
“Approximately 1% to 2% of the human genome consists of CpG dinucleotides, whose methylation is inversely related to the transcriptional activity in cells [81].”
BackgroundDolinoy, D. C. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00056.x · Cited by 280
Chen, P. S., Wang, C.-C., Bortner, C. D., Peng, G.-S., Wu, X., Pang, H., Lu, R.-B., Gean, P.-W., Chuang, D.-M., & Hong, J.-S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.06.053 · Cited by 262 · cited 1×
“VPA, similar to other histone deacetylase inhibitors, such as trichostatin A and sodium butyrate, induced apoptosis in cultured microglial cells obtained from the brains of 2-day-old rat pups [37].”
BackgroundPrenatal factors associated with autism spectrum disorder (ASD)
Ornoy, A., Weinstein-Fudim, L., & Ergaz, Z. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.05.007 · Cited by 238
Self-citationPerinatal Choline Effects on Neonatal Pathophysiology Related to Later Schizophrenia Risk
Ross, R. G., Hunter, S. K., McCarthy, L., Beuler, J., Hutchison, A. K., Wagner, B. D., Leonard, S., Stevens, K. E., & Freedman, R. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070940 · Cited by 165
Is autism due to brain desynchronization?
Welsh, J. P., Ahn, E. S., & Placantonakis, D. G. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.09.002 · Cited by 108
Numata, S., Ishii, K., Tajima, A., Iga, J.-I., Kinoshita, M., Watanabe, S., Umehara, H., Fuchikami, M., Okada, S., Boku, S., et al. (2015) · Epigenetics · doi:10.1080/15592294.2014.1003743 · Cited by 79
Roost, M. S., Slieker, R. C., Bialecka, M., van Iperen, L., Gomes Fernandes, M. M., He, N., Suchiman, H. E. D., Szuhai, K., Carlotti, F., de Koning, E. J. P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01077-3 · Cited by 65 · cited 2×
“The investigations of biopsies obtained from specific organs of human embryos demonstrated that the DNA methylation trajectory in the embryo undergoes considerable remodeling and modulations during the first to the second trimester of gestation (9, 18, and 22 weeks) [6,94].”
BackgroundPerinatal stress and epigenetics.
(2021) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-820107-7.00008-2 · Cited by 28
Research works printed but not linked: 128
- Szyf, 2015, Prospects for the development of epigenetic drugs for CNS conditions, Nat. Rev. Drug Discov., 14, 461, 10.1038/nrd4580 · DOI
- Chiarella, 2020, DNA methylation differences in stress-related genes, functional connectivity and gray matter volume in depressed and healthy adolescents, J. Affect. Disord., 271, 160, 10.1016/j.jad.2020.03.062 · DOI
- Petropoulos, 2015, Gestational Diabetes Alters Offspring DNA Methylation Profiles in Human and Rat: Identification of Key Pathways Involved in Endocrine System Disorders, Insulin Signaling, Diabetes Signaling, and ILK Signaling, Endocrinology, 156, 2222, 10.1210/en.2014-1643 · DOI
- Xia, 2020, Rebooting the Epigenomes during Mammalian Early Embryogenesis, Stem Cell Rep., 15, 1158, 10.1016/j.stemcr.2020.09.005 · DOI
- Reizel, 2018, Postnatal DNA demethylation and its role in tissue maturation, Nat. Commun., 9, 2040, 10.1038/s41467-018-04456-6 · DOI · Paper page
- Nagy, 2012, Sensitive periods in epigenetics: Bringing us closer to complex behavioral phenotypes, Epigenomics, 4, 445, 10.2217/epi.12.37 · DOI · Paper page
- Burns, 2018, Plasticity of the epigenome during early-life stress, Semin. Cell Dev. Biol., 77, 115, 10.1016/j.semcdb.2017.09.033 · DOI
- Ornoy, 2010, Alcohol abuse in pregnant women: Effects on the fetus and newborn, mode of action and maternal treatment, Int. J. Environ. Res. Public Health, 7, 364, 10.3390/ijerph7020364 · DOI · Paper page
- Rice, 2000, Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models, Environ. Health Perspect., 108, 511
- Lucassen, 2013, Perinatal programming of adult hippocampal structure and function; emerging roles of stress, nutrition and epigenetics, Trends Neurosci., 36, 621, 10.1016/j.tins.2013.08.002 · DOI · Paper page
- Li, 2020, Epigenomic programming in early fetal brain development, Epigenomics, 12, 1053, 10.2217/epi-2019-0319 · DOI
- Bottom, 2020, Rescue of ethanol-induced FASD-like phenotypes via prenatal co-administration of choline, Neuropharmacology, 168, 107990, 10.1016/j.neuropharm.2020.107990 · DOI
- Wozniak, 2020, Four-year follow-up of a randomized controlled trial of choline for neurodevelopment in fetal alcohol spectrum disorder, J. Neurodev. Disord., 12, 9, 10.1186/s11689-020-09312-7 · DOI
- Ornoy, 2019, S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice, Neurotoxicol. Teratol., 71, 64, 10.1016/j.ntt.2018.01.005 · DOI · Paper page
- Weinstein-Fudim, L., Ergaz, Z., Turgeman, G., Yanai, J., Szyf, M., and Ornoy, A. (2019). Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior?. Int. J. Mol. Sci., 20. · DOI · Paper page
- Tran, 2019, The Combination of Metformin and Valproic Acid Has a Greater Anti-tumoral Effect on Prostate Cancer Growth In Vivo than Either Drug Alone, Vivo, 33, 99, 10.21873/invivo.11445 · DOI
- Kaaja, 2003, Major malformations in offspring of women with epilepsy, Neurology, 60, 575, 10.1212/01.WNL.0000044157.28073.DC · DOI · Paper page
- Vajda, 2007, The Australian Register of Antiepileptic Drugs in Pregnancy: The first 1002 pregnancies, Aust. N. Z. J. Obstet. Gynaecol., 47, 468, 10.1111/j.1479-828X.2007.00781.x · DOI
- Bromfield, 2008, Valproate teratogenicity and epilepsy syndrome, Epilepsia, 49, 2122, 10.1111/j.1528-1167.2008.01696.x · DOI
- Binkerd, 1988, Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats, Fundam. Appl. Toxicol., 11, 485, 10.1016/0272-0590(88)90112-1 · DOI
- Wagner, 2006, A new neurobehavioral model of autism in mice: Pre- and postnatal exposure to sodium valproate, J. Autism Dev. Disord., 36, 779, 10.1007/s10803-006-0117-y · DOI · Paper page
- Rodier, 1996, Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei, J. Comp. Neurol., 370, 247, 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2 · doi:10.1002/(sici)1096-9861(19960624)370:2<247::aid-cne8>3.0.co;2-2
- Ergaz, 2019, Prevention or Amelioration of Autism-Like Symptoms in Animal Models: Will it Bring Us Closer to Treating Human ASD?, Int. J. Mol. Sci., 20, 1074, 10.3390/ijms20051074 · DOI · Paper page
- Choi, 2016, The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy, Sci. Rep., 6, 36250, 10.1038/srep36250 · DOI
- Phiel, 2001, Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen, J. Biol. Chem., 276, 36734, 10.1074/jbc.M101287200 · DOI · Paper page
- Wiltse, 2005, Mode of action: Inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin—Developmental effects of valproic acid, Crit. Rev. Toxicol., 35, 727, 10.1080/10408440591007403 · DOI
- Gurvich, 2005, Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo, FASEB J., 19, 1166, 10.1096/fj.04-3425fje · DOI · Paper page
- Menegola, 2006, Inhibition of histone deacetylase as a new mechanism of teratogenesis, Birth Defects Res. Part C Embryo Today, 78, 345, 10.1002/bdrc.20082 · DOI
- Quina, 2006, Chromatin structure and epigenetics, Biochem. Pharmacol., 72, 1563, 10.1016/j.bcp.2006.06.016 · DOI · Paper page
- Bannister, 2005, Reversing histone methylation, Nature, 436, 1103, 10.1038/nature04048 · DOI · Paper page
- Shafique, 2021, Gestational valproic acid exposure induces epigenetic modifications in murine decidua, Placenta, 107, 31, 10.1016/j.placenta.2021.03.004 · DOI
- Felisbino, 2021, Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways, Sci. Rep., 11, 2163, 10.1038/s41598-021-81794-4 · DOI
- Roy, 2008, Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency, J. Cell. Biochem., 105, 467, 10.1002/jcb.21847 · DOI
- Guo, W., Tsujimura, K., Otsuka, I.M., Irie, K., Igarashi, K., Nakashima, K., and Zhao, X. (2014). VPA alleviates neurological deficits and restores gene expression in a mouse model of Rett syndrome. PLoS ONE, 9. · DOI
- Cohen, 2013, Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats, Int. J. Dev. Neurosci., 31, 740, 10.1016/j.ijdevneu.2013.09.002 · DOI
- Jacob, 2014, Valproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndrome, Dis. Models Mech., 7, 107
- Heers, 2018, Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer, Eur. J. Pharmacol., 835, 61, 10.1016/j.ejphar.2018.07.057 · DOI
- Jahani, 2021, Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells, J. Gastrointest. Cancer, 52, 676, 10.1007/s12029-019-00332-8 · DOI
- Granato, 2017, Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells, Cell Oncol., 40, 167, 10.1007/s13402-017-0314-z · DOI
- Gravemann, 2008, Hydroxamic acid and fluorinated derivatives of valproic acid: Anticonvulsant activity, neurotoxicity and teratogenicity, Neurotoxicol. Teratol., 30, 390, 10.1016/j.ntt.2008.03.060 · DOI
- Modi, 2014, Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4, Bipolar Disord., 16, 875, 10.1111/bdi.12220 · DOI
- Binder, 2006, Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy, J. Perinat. Med., 34, 383, 10.1515/JPM.2006.077 · DOI
- Lu, 2000, S-Adenosylmethionine, Int. J. Biochem. Cell Biol., 32, 391, 10.1016/S1357-2725(99)00139-9 · DOI · Paper page
- Panmanee, 2019, Control and regulation of S-Adenosylmethionine biosynthesis by the regulatory β subunit and quinolone-based compounds, FEBS J., 286, 2135, 10.1111/febs.14790 · DOI
- Cantoni, 1975, Biological methylation: Selected aspects, Annu. Rev. Biochem., 44, 435, 10.1146/annurev.bi.44.070175.002251 · DOI · Paper page
- Mato, 1997, S-adenosylmethionine synthesis: Molecular mechanisms and clinical implications, Pharmacol. Ther., 73, 265, 10.1016/S0163-7258(96)00197-0 · DOI · Paper page
- Orsolini, 2016, A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder, CNS Neurol. Disord. Drug Targets, 15, 35, 10.2174/1871527314666150821103825 · DOI
- Cuomo, 2020, S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review, Ann. Gen. Psychiatry, 19, 50, 10.1186/s12991-020-00298-z · DOI
- Sarris, 2020, S-Adenosylmethionine (SAMe) monotherapy for depression: An 8-week double-blind, randomised, controlled trial, Psychopharmacology, 237, 209, 10.1007/s00213-019-05358-1 · DOI
- Jacobsen, 1991, Oral S-adenosylmethionine in Primary Fibromyalgia. Double-blind Clinical Evaluation, Scand. J. Rheumatol., 20, 294, 10.3109/03009749109096803 · DOI
- Shekim, 1990, S-adenosyl-L-methionine (SAM) in adults with ADHD, RS: Preliminary results from an open trial, Psychopharmacol. Bull., 26, 249
- Rogers, 2000, S-Adenosyl-Methionine improves depression in patients with Parkinson’s disease in an open-label clinical trial, Mov. Disord., 15, 1225, 10.1002/1531-8257(200011)15:6<1225::AID-MDS1025>3.0.CO;2-A · DOI
- Beauchamp, 2020, S-Adenosylmethionine Rescues Cognitive Deficits in the rTg4510 Animal Model by Stabilizing Protein Phosphatase 2A and Reducing Phosphorylated Tau, J. Alzheimer’s Dis. JAD, 77, 1705, 10.3233/JAD-200756 · DOI
- 1987, A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis, Am. J. Med., 83, 89, 10.1016/0002-9343(87)90859-X · doi:10.1016/0002-9343(87)90859-x
- Friedel, 1989, S-Adenosyl-L-Methionine, Drugs, 38, 389, 10.2165/00003495-198938030-00004 · DOI · Paper page
- Corpa, 2003, Effects of S-adenosylmethionine on hepatic regeneration after partial hepatectomy in the rat, J. Physiol. Biochem., 59, 63, 10.1007/BF03179869 · doi:10.1007/bf03179869
- Purohit, 2007, Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: Summary of a symposium, Am. J. Clin. Nutr., 86, 14, 10.1093/ajcn/86.1.14 · DOI · Paper page
- Qiao, 2021, Therapeutic effect of adenosylmethionine on viral hepatitis and related factors inducing diseas, Am. J. Transl. Res., 13, 9485
- Ilisso, 2016, S-Adenosylmethionine Affects ERK1/2 and Stat3 Pathways and Induces Apotosis in Osteosarcoma Cells, J. Cell. Physiol., 231, 428, 10.1002/jcp.25089 · DOI
- Mahmood, 2018, Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications, Oncotarget, 9, 5169, 10.18632/oncotarget.23704 · DOI
- Ilisso, 2015, The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines, Endocrine, 50, 212, 10.1007/s12020-014-0484-7 · DOI
- Yang, 2009, Pharmacokinetic properties of S-adenosylmethionine after oral and intravenous administration of its tosylate disulfate salt: A multiple-dose, open-label, parallel-group study in healthy Chinese volunteers, Clin. Ther., 31, 311, 10.1016/j.clinthera.2009.02.010 · DOI
- Smith, 2015, Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome, Diabetes Metab. Syndr. Obes., 8, 295
- Maude, 2021, Epigenetics of Hepatic Insulin Resistance, Front. Endocrinol., 12, 504, 10.3389/fendo.2021.681356 · DOI
- Villagra, 2017, The Importance of ncRNAs as Epigenetic Mechanisms in Phenotypic Variation and Organic Evolution, Front. Microbiol., 8, 2483, 10.3389/fmicb.2017.02483 · DOI
- Jaeger, 2018, Epigenetic control of gene regulation during development and disease: A view from the retina, Prog. Retin. Eye Res., 65, 1, 10.1016/j.preteyeres.2018.03.002 · DOI
- Dindot, 2009, Epigenetic profiling at mouse imprinted gene clusters reveals novel epigenetic and genetic features at differentially methylated regions, Genome Res., 19, 1374, 10.1101/gr.089185.108 · DOI
- Matouk, 2008, Epigenetic regulation of vascular endothelial gene expression, Circ. Res., 102, 873, 10.1161/CIRCRESAHA.107.171025 · DOI · Paper page
- Golding, 2011, Examination of DNA methyltransferase expression in cloned embryos reveals an essential role for Dnmt1 in bovine development, Mol. Reprod. Dev., 78, 306, 10.1002/mrd.21306 · DOI
- Wang, 2017, S-adenosyl-methionine (SAM) alters the transcriptome and methylome and specifically blocks growth and invasiveness of liver cancer cells, Oncotarget, 8, 111866, 10.18632/oncotarget.22942 · DOI
- Chouliaras, 2013, Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer’s disease patients, Neurobiol. Aging, 34, 2091, 10.1016/j.neurobiolaging.2013.02.021 · DOI · Paper page
- Indika, 2021, Sulfur amino acid metabolism and related metabotypes of autism spectrum disorder: A review of biochemical evidence for a hypothesis, Biochimie, 184, 143, 10.1016/j.biochi.2021.02.018 · DOI
- Lozano, 2014, S-adenosylmethionine Levels Regulate the Schwann Cell DNA Methylome, Neuron, 81, 1024, 10.1016/j.neuron.2014.01.037 · DOI
- Wilson, 1984, Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet, Biochem. J., 218, 987, 10.1042/bj2180987 · DOI
- Lu, 2012, S-adenosylmethionine in liver health, injury, and cancer, Physiol. Rev., 92, 1515, 10.1152/physrev.00047.2011 · DOI · Paper page
- Guo, 2014, The DNA methylation landscape of human early embryos, Nature, 511, 606, 10.1038/nature13544 · DOI · Paper page
- Smith, 2014, DNA methylation dynamics of the human preimplantation embryo, Nature, 511, 611, 10.1038/nature13581 · DOI · Paper page
- Lee, 2014, Reprogramming the methylome: Erasing memory and creating diversity, Cell Stem Cell, 14, 710, 10.1016/j.stem.2014.05.008 · DOI · Paper page
- Nguyen, 2007, Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan, Dev. Dyn., 236, 1663, 10.1002/dvdy.21176 · DOI · Paper page
- Slieker, 2015, DNA Methylation Landscapes of Human Fetal Development, PLoS Genet., 11, e1005583, 10.1371/journal.pgen.1005583 · DOI
- Chen, 2017, Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1, Biol. Chem., 398, 785, 10.1515/hsz-2016-0307 · DOI
- Peñagaricano, F., Souza, A.H., Carvalho, P.D., Driver, A.M., Gambra, R., Kropp, J., Hackbart, K.S., Luchini, D., Shaver, R.D., and Wiltbank, M.C. (2013). Effect of maternal methionine supplementation on the transcriptome of bovine preimplantation embryos. PLoS ONE, 8. · DOI
- Fournier, 2016, Responses of bovine early embryos to S-adenosyl methionine supplementation in culture, Epigenomics, 8, 1039, 10.2217/epi-2016-0022 · DOI
- Cooney, 2002, Maternal Methyl Supplements in Mice Affect Epigenetic Variation and DNA Methylation of Offspring, J. Nutr., 132, 2393S, 10.1093/jn/132.8.2393S · DOI · Paper page
- Jones, 1998, Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription, Nat. Genet., 19, 187, 10.1038/561 · DOI · Paper page
- Duhl, 1994, Neomorphic agouti mutations in obese yellow mice, Nat. Genet., 8, 59, 10.1038/ng0994-59 · DOI · Paper page
- Waterland, 2003, Transposable elements: Targets for early nutritional effects on epigenetic gene regulation, Mol. Cell. Biol., 23, 5293, 10.1128/MCB.23.15.5293-5300.2003 · DOI · Paper page
- Jirtle, 2007, Environmental epigenomics and disease susceptibility, Nat. Rev. Genet., 8, 253, 10.1038/nrg2045 · DOI · Paper page
- Weinstein-Fudim, L., Ergaz, Z., Szyf, M., and Ornoy, A. (2020). Prenatal S-Adenosine Methionine (SAMe) Induces Changes in Gene Expression in the Brain of Newborn Mice That Are Prevented by Co-Administration of Valproic Acid (VPA). Int. J. Mol. Sci., 21. · DOI
- Ornoy, A., Becker, M., Weinstein-Fudim, L., and Ergaz, Z. (2020). S-Adenosine Methionine (SAMe) and Valproic Acid (VPA) as Epigenetic Modulators: Special Emphasis on their Interactions Affecting Nervous Tissue during Pregnancy. Int. J. Mol. Sci., 21. · DOI · Paper page
- Feder, 2010, Selective breeding for dominant and submissive behavior in Sabra mice, J. Affect. Disord., 126, 214, 10.1016/j.jad.2010.03.018 · DOI
- Becker, M., Pinhasov, A., and Ornoy, A. (2021). Animal Models of Depression: What Can They Teach Us about the Human Disease?. Diagnostics, 11. · DOI · Paper page
- Becker, M., Abaev, K., Pinhasov, A., and Ornoy, A. (J. Behav. Brain Res., 2022). S-adenosyl methionine alleviates depression like behavior in a mouse model of social hierarchy, J. Behav. Brain Res., article under review.
- Frezza, 1990, S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial, Hepato-Gastroenterol., 37, 122
- Coltorti, 1990, A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis, Methods Find. Exp. Clin. Pharmacol., 12, 69
- Hardy, 2003, S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease, Evid. Rep./Technol. Assess., 64, 1
- Cozens, 1988, Reproductive toxicity studies of ademetionine, Arzneim. -Forsch., 38, 1625
- Zeisel, 1994, Choline and human nutrition, Annu. Rev. Nutr., 14, 269, 10.1146/annurev.nu.14.070194.001413 · DOI · Paper page
- Zeisel, 2018, Choline, Adv. Nutr., 9, 58, 10.1093/advances/nmx004 · DOI
- Caudill, 2010, Pre- and postnatal health: Evidence of increased choline needs, J. Am. Diet. Assoc., 110, 1198, 10.1016/j.jada.2010.05.009 · DOI · Paper page
- Cohen, 1976, Brain acetylcholine: Control by dietary choline, Science, 191, 561, 10.1126/science.1251187 · DOI · Paper page
- Filgueiras, 2011, Developmental aspects of the cholinergic system, Behav. Brain Res., 221, 367, 10.1016/j.bbr.2009.12.049 · DOI · Paper page
- Zeisel, 2006, Perinatal choline influences brain structure and function, Nutr. Rev., 64, 197, 10.1111/j.1753-4887.2006.tb00202.x · DOI · Paper page
- Hoffmann, 2013, Osmotic regulation of hepatic betaine metabolism, Am. J. Physiology. Gastrointest. Liver Physiol., 304, G835, 10.1152/ajpgi.00332.2012 · DOI
- Traiffort, 2013, The choline transporter-like family SLC44: Properties and roles in human diseases, Mol. Asp. Med., 34, 646, 10.1016/j.mam.2012.10.011 · DOI
- Lu, 2001, Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation, Proc. Natl. Acad. Sci. USA, 98, 5560, 10.1073/pnas.091016398 · DOI · Paper page
- Albright, 1999, Choline availability alters embryonic development of the hippocampus and septum in the rat, Brain Res. Dev. Brain Res., 113, 13, 10.1016/S0165-3806(98)00183-7 · DOI · Paper page
- Albright, 2001, Maternal choline availability alters the localization of p15Ink4B and p27Kip1 cyclin-dependent kinase inhibitors in the developing fetal rat brain hippocampus, Dev. Neurosci., 23, 100, 10.1159/000048701 · DOI
- Kwan, S.T.C., King, J.H., Grenier, J.K., Yan, J., Jiang, X., Roberson, M.S., and Caudill, M.A. (2018). Maternal Choline Supplementation during Normal Murine Pregnancy Alters the Placental Epigenome: Results of an Exploratory Study. Nutrients, 10. · DOI
- Kwan, 2017, Maternal choline supplementation during murine pregnancy modulates placental markers of inflammation, apoptosis and vascularization in a fetal sex-dependent manner, Placenta, 53, 57, 10.1016/j.placenta.2017.03.019 · DOI
- Cheng, 2008, Prenatal choline supplementation alters the timing, emotion, and memory performance (TEMP) of adult male and female rats as indexed by differential reinforcement of low-rate schedule behavior, Learn Mem., 15, 153, 10.1101/lm.729408 · DOI
- Meck, 1999, Choline supplementation during prenatal development reduces proactive interference in spatial memory, Brain Res. Dev. Brain Res., 118, 51, 10.1016/S0165-3806(99)00105-4 · DOI · Paper page
- Friday, 2019, Low availability of choline in utero disrupts development and function of the retina, FASEB J., 33, 9194, 10.1096/fj.201900444R · DOI
- May, 2018, Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities, JAMA, 319, 474, 10.1001/jama.2017.21896 · DOI · Paper page
- Wozniak, 2019, Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder, Lancet Neurol., 18, 760, 10.1016/S1474-4422(19)30150-4 · DOI · Paper page
- Lussier, 2016, DNA methylation signature of human fetal alcohol spectrum disorder, Epigenetics Chromatin, 9, 25, 10.1186/s13072-016-0074-4 · DOI · Paper page
- Steane, 2021, Maternal choline supplementation in a rat model of periconceptional alcohol exposure: Impacts on the fetus and placenta, Alcohol Clin. Exp. Res., 45, 2130, 10.1111/acer.14685 · DOI
- Sawant, 2019, Maternal choline supplementation mitigates alcohol-induced fetal cranio-facial abnormalities detected using an ultrasonographic examination in a sheep model, Alcohol, 81, 31, 10.1016/j.alcohol.2019.05.001 · DOI
- Jacobson, 2018, Efficacy of Maternal Choline Supplementation During Pregnancy in Mitigating Adverse Effects of Prenatal Alcohol Exposure on Growth and Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Alcohol Clin. Exp. Res., 42, 1327, 10.1111/acer.13769 · DOI
- Warton, 2021, Maternal choline supplementation mitigates alcohol exposure effects on neonatal brain volumes, Alcohol Clin. Exp. Res., 45, 1762, 10.1111/acer.14672 · DOI
- Kable, 2015, The impact of micronutrient supplementation in alcohol-exposed pregnancies on information processing skills in Ukrainian infants, Alcohol, 49, 647, 10.1016/j.alcohol.2015.08.005 · DOI
- Boeke, 2013, Choline intake during pregnancy and child cognition at age 7 years, Am. J. Epidemiol., 177, 1338, 10.1093/aje/kws395 · DOI · Paper page
- Caudill, 2018, Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: A randomized, double-blind, controlled feeding study, FASEB J., 32, 2172, 10.1096/fj.201700692RR · DOI · Paper page
- Freedman, 2019, Higher Gestational Choline Levels in Maternal Infection Are Protective for Infant Brain Development, J. Pediatrics, 208, 198, 10.1016/j.jpeds.2018.12.010 · DOI
- Cheatham, 2012, Phosphatidylcholine supplementation in pregnant women consuming moderate-choline diets does not enhance infant cognitive function: A randomized, double-blind, placebo-controlled trial, Am. J. Clin. Nutr., 96, 1465, 10.3945/ajcn.112.037184 · DOI
- Wozniak, 2015, Choline supplementation in children with fetal alcohol spectrum disorders: A randomized, double-blind, placebo-controlled trial, Am. J. Clin. Nutr., 102, 1113, 10.3945/ajcn.114.099168 · DOI
- Sarkar, 2019, Persistent Changes in Stress-Regulatory Genes in Pregnant Women or Children Exposed Prenatally to Alcohol, Alcohol Clin. Exp. Res., 43, 1887, 10.1111/acer.14148 · DOI
- Nguyen, 2016, Randomized, double-blind, placebo-controlled clinical trial of choline supplementation in school-aged children with fetal alcohol spectrum disorders, Am. J. Clin. Nutr., 104, 1683, 10.3945/ajcn.116.142075 · DOI
Cited by
Ornoy, A., Echefu, B., & Becker, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910469 · Cited by 41
Self-citation
Metadata
- Authors
- Ornoy, A., Weinstein-Fudim, L., & Becker, M.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2022-02-03
- Volume
- 15
- Issue
- 2
- Pages
- 192
- ISSN
- 1424-8247
- Cited by
- 17
- References
- 17
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.